Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04677153 · ClinicalTrials.gov registry record · NA
Rapid HCV Treatment Access for Persons Who Use Drugs
A NA study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 198
- Enrollment target
NCT04677153: Completed NA study, sponsored by Johns Hopkins University.
NCT04677153 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 198 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04677153, a NA study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 198 participants
- Enrollment target
Study Summary
This study is being done to compare two strategies to deliver HCV treatment to persons with hepatitis C virus (HCV) who also use drugs and are participating in an outpatient opioid treatment program (OTP). Participants will be randomized into one of two treatment groups: 1. Test and treat plus peer-mentors: This treatment group will be offered 8 weeks of glecaprevir/pibrentasvir (an FDA approved HCV treatment) within days of HCV diagnosis at the OTP. Participants in this group will receive treatment adherence support from a peer-mentor who is someone who has been cured of HCV infection. 2. Standard of care HCV treatment referral: This treatment group will be referred to an offsite HCV treatment location. This is the usual care for anyone who tests positive for HCV at the OTP who is not participating in this study.
Interventions
- OTHER Usual care
- OTHER Test and treat plus peer mentors
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 198 participants |
| Start Date | 2021-08-06 |
| Est. Completion | 2024-09-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04677153
The ClinicalTrials.gov registry entry for NCT04677153 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 198 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Usual care is the first listed.
NCT04677153 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04677153 about?
NCT04677153 is a clinical study titled "Rapid HCV Treatment Access for Persons Who Use Drugs". This study is being done to compare two strategies to deliver HCV treatment to persons with hepatitis C virus (HCV) who also use drugs and are participating in an outpatient opioid treatment program (OTP). Participants will be randomized into one of two treatment groups: 1. Test and treat plus peer...
What is the current status of trial NCT04677153?
This trial is currently completed. It is a NA study. The enrollment target is 198 participants. The study started on 2021-08-06. Estimated completion is 2024-09-23.
What interventions are being tested in trial NCT04677153?
The interventions under investigation include: Usual care (OTHER), Test and treat plus peer mentors (OTHER).
Who is sponsoring clinical trial NCT04677153?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.